Specialty Chemicals company Jubilant Ingrevia announced Q1FY26 results Total Revenue: Rs 1,038 crore compared to Rs 1,024 crore during Q1FY25, change 1%. EBITDA: Rs 153 crore compared to Rs 119 crore during Q1FY25, change 29%. EBITDA Margin: 15% for Q1FY26. PAT: Rs 75 crore compared to Rs 49 crore during Q1FY25, change 54%. PAT Margin: 7% for Q1FY26. EPS: Rs 4.7 for Q1FY26. Shyam S Bhartia, Chairman & Hari S Bhartia, Co-Chairman, Jubilant Ingrevia, said: “We are pleased to present the financial results for the first quarter of this fiscal year. Our specialty chemical businesses have continued to perform strongly, growing double digit YoY and with stable performance on QoQ basis. Our Chemical Intermediates business has started to recover marginally with QoQ growth. Ongoing cost optimisation initiatives have further enhanced profitability, with EBITDA for the quarter rising by 29% YoY and Profit After Tax increasing by an impressive 54% YoY. Result PDF
Conference Call with Jubilant Ingrevia Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Jubilant Ingrevia announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Total Revenue: Rs 1,051 crore in Q4FY25 vs. Rs 1,074 crore in Q4FY24 — down 2% Total EBITDA: Rs 155 crore in Q4FY25 vs. Rs 101 crore in Q4FY24 — up 54% EBITDA Margin (%): 15% in Q4FY25 vs. 9% in Q4FY24 — up 600 bps Profit After Tax (PAT): Rs 74 crore in Q4FY25 vs. Rs 29 crore in Q4FY24 — up 153% PAT Margin (%): 7% in Q4FY25 vs. 3% in Q4FY24 — up 400 bps Basic and Diluted EPS: Rs 4.7 in Q4FY25 vs. Rs 1.8 in Q4FY24 — up 153% FY25 Financial Highlights: Total Revenue: Rs 4,178 crore in FY25 vs. Rs 4,136 crore in FY24 — up 1% Total EBITDA: Rs 557 crore in FY25 vs. Rs 456 crore in FY24 — up 22% EBITDA Margin (%): 13% in FY25 vs. 11% in FY24 — up 200 bps Profit After Tax (PAT): Rs 251 crore in FY25 vs. Rs 183 crore in FY24 — up 37% PAT Margin (%): 6% in FY25 vs. 4% in FY24 — up 200 bps Basic and Diluted EPS: Rs 15.9 in FY25 vs. Rs 11.6 in FY24 — up 37% Result PDF
Conference Call with Jubilant Ingrevia Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Jubilant Ingrevia announced Q3FY25 results Total Revenue: Rs 1,057 crore compared to Rs 966 crore during Q3FY24, change 9.4%. EBITDA: Rs 148 crore compared to Rs 104 crore during Q3FY24, change 41.5%. EBITDA Margin: 14% for Q3FY25. PAT: Rs 69 crore compared to Rs 39 crore during Q3FY24, change 80%. PAT margin: 7% for Q3FY25. EPS: Rs 4.4 for Q3FY25. Shyam S Bhartia, Chairman & Hari S Bhartia, Co-Chairman, Jubilant Ingrevia, said: “We are pleased to announce significant YoY growth for this quarter, attributed to the enhanced performance of our Speciality Chemicals and Nutrition businesses, as well as to the benefits derived from costsaving initiatives implemented in recent quarters. We are also glad to share that the Board has recommended an interim dividend of 250%, which equates to Rs 2.5 per equity share with a face value of Rs 1 each for FY25. This will result in a cash outflow of Rs 39.8 Crore Result PDF